维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="BELLO CL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Circulating protein biomarks of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma:modulation of VEGF and VEGRrelated proteins显示文摘	Deprimo SE Bello CL Smeraglia J	2007	J Transl Med2007，5，：	1
2	Effect of food on the pharmacokinetics of sunitinib malate ( SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects 显示文摘	BELLO CL SHERMAN L ZHOU J	2006	Anticancer Drugs2006，17，3：	1
3	Exposure-response of sunitinib in metastatic renal cell carcinoma ( mRCC) : A popu-lalion pharmacokinetic/pharmacodyna-mic( PKPD) approach显示文摘	Houk BE Bello CL Michaelson MD	2007	J Clin Oncol2007，25，18：	1
4	Effet al of food on the pharmacokinetics of sunitinib malate (SUl1248), a multi- targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects显示文摘	Bello CL Sherman L Zhou J	2006	Anticancer Drugs2006，17，3：	1
5	Pharmacokinetic and pharrnacodynamic evaluation of SU11248 in a phase Ⅰ clinical trial of patients (pts) with imatinib-resistant gastrointestinal stromal tumor (GIST) 显示文摘	Manning WC Bello CL Deprimo SE	2003	J Proc Am Soc Clin Oncol2003，22，1：	1
6	Pharmacokinetic and pharmacodynamic evaluation of SU11248 in a phase I clinical trial of patients with imatinib-resistant stromal tumors显示文摘	Manning WC Bello CL Deprimo SE	2003	Proc ASCO2003，22，：	1
7	Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma:modulation of VEGF and VEGF-related proteins显示文摘	Deprimo SE Bello CL Smeraglia J	2007	J Transl Med2007，5，1：	1
8	Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma:modulation of VEGF and VEGF-related proteins显示文摘	De Primo SE Bello CL Smeraglia J	2007	J Transl Med2007，5，：	1
9	A phase I, open-label, mass balancestudy of dacomitinib (PF- 00299804) in healthy male volunteers 显示文摘	BELLO CL SMITH E RUIZ-GARCIA A	2013	Cancer Chemother Pharmacol2013，72，2：	1
10	Effect of food on the pharmacokineties of sunitinib rnalate(SU1 1248),a muhi-targeted receptor tyrosine kinase inhibitor:results from a phase I study in healthy subjects显示文摘	BELLO CL SHERMAN L ZHOU J	2006	Anticancer Drugs2006，17，3：	1
11	A population pharmacokinetic meta - analysis of sunitinib malate ( SU11248 ) and its primary me- tabolite (SU12662) in healthy volunteers and oncology patients显示文摘	Houk BE Bello CL Kang D	2009	Clin Cancer Res2009，15，：	1
12	A phase I , open - la- bel, mass balanee study of dacomitinib ( PF - 00299804) in healthy male volunteers显示文摘	Bello CL Smith E Ruiz - Garcia A	2013	Cancer Chemother Pharmacol2013，72，：	1
13	Single- and multiple- dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species 显示文摘	Haznedar JO Patyna S Bello CL	2009	Cancer Chemother Pharmacol2009，64，4：	1
14	Relationship betwan exlrsure m sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic recta- analysis显示文摘	Houk BE Bello CL Poland B	2010	Cancer Chemother Pharmacol2010，66，2：	1
15	Cloning of Gossypium hirsutum sucrose non-fermenting 1-relatedprotein kinase 2 gene (GhSnRK2) and its overexpression in transgenicArabidopsis escalates drought and low temperature tolerance 显示文摘	Bello B Zhang XY Liu CL Yang ZE Yang ZR Wang QH Zhao G LiFG	2014	PLoSONE2014，9，11：	1
16	Sunitinib malate for the treatment of solid tumours : a review of current clinical data 显示文摘	MOTZER RJ HOOSEN S BELLO CL	2006	Expert Opin lnvestig Drugs2006，15，5：	1
17	Sunitinib malate for the treatment of solid tumours: a review of current clinical data显示文摘	Motzer R J Hoosen S Bello CL	2006	Expert Opin Invest Drugs2006，15，5：	1
18	Sunitinib malate for the treatment of solid tumours:a review of current clinical data显示文摘	Motzer RJ Hoosen S Bello CL	2006	Expert Opin Investig Drugs2006，15，5：	1
19	Pharmacokinetics of sunitinib malate in subjects with hepatic impairment 显示文摘	Bello CL Garrett M Sherman L	2010	Cancer Chemother Pharmacol2010，66，4：	1
20	Sunitinib malate for the treatment of solid tumours: a review of current clinical data显示文摘	Motzeb IU Hoosen S Bello CL	2006	Expert Opin Investig Drugs2006，15，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示